Novel Acylethanolamide Derivatives That Modulate Body Weight through Enhancement of Hypothalamic Pro-Opiomelanocortin (POMC) and/or Decreased Neuropeptide Y (NPY)-Reference-Cited by-同舟云学术

Novel Acylethanolamide Derivatives That Modulate Body Weight through Enhancement of Hypothalamic Pro-Opiomelanocortin (POMC) and/or Decreased Neuropeptide Y (NPY)

Published:2013-03-01 Issue:5 Volume:56 Page:1811-1829
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Avraham Yosefa¹,Katzhendler Jehoshua²,Vorobeiv Lia¹,Merchavia Shira¹,Listman Chana¹,Kunkes Eithan¹,Harfoush Fida’³,Salameh Sawsan³,Ezra Aviva F.²,Grigoriadis Nikolaos C.⁴,Berry Elliot M.¹,Najajreh Yousef³

Affiliation:

1. Department of Human Nutrition and Metabolism, Braun School of Public Health, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel

2. Institute of Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, 91120 Jerusalem, Israel

3. Anticancer Drugs Research Lab, Faculty of Pharmacy, Al-Quds University, Abu-Dies, P.O. Box 20002, Jerusalem, Palestinian Authority

4. Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm300484d

Reference90 articles.

1. The Epidemiology of Obesity

2. The prevalence and costs of obesity in the EU